许泽艳, 杨志贤, 廖承德, 杨军, 丁莹莹. 合并甲状腺癌的多原发性癌的临床及病理特征分析[J]. 中国肿瘤临床, 2018, 45(18): 955-958. DOI: 10.3969/j.issn.1000-8179.2018.18.732
引用本文: 许泽艳, 杨志贤, 廖承德, 杨军, 丁莹莹. 合并甲状腺癌的多原发性癌的临床及病理特征分析[J]. 中国肿瘤临床, 2018, 45(18): 955-958. DOI: 10.3969/j.issn.1000-8179.2018.18.732
Xu Zeyan, Yang Zhixian, Liao Chengde, Yang Jun, Ding Yingying. Clinical and pathological features of multiple primary malignancies involving thyroid cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(18): 955-958. DOI: 10.3969/j.issn.1000-8179.2018.18.732
Citation: Xu Zeyan, Yang Zhixian, Liao Chengde, Yang Jun, Ding Yingying. Clinical and pathological features of multiple primary malignancies involving thyroid cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(18): 955-958. DOI: 10.3969/j.issn.1000-8179.2018.18.732

合并甲状腺癌的多原发性癌的临床及病理特征分析

Clinical and pathological features of multiple primary malignancies involving thyroid cancer

  • 摘要:
      目的  分析合并甲状腺癌的多原发性癌患者的临床及病理特征。
      方法  回顾性分析2007年10月至2017年3月云南省肿瘤医院确诊的4 861例甲状腺癌患者,从中筛选出290例(5.97%)合并其他恶性肿瘤的多原发癌患者,分析其临床及病理特征。
      结果  筛选出290例甲状腺癌患者,其中7例(2.4%)为三原发性恶性肿瘤,283例(97.6%)为双原发性恶性肿瘤。以肿瘤发生时间分类:83例(28.6%)为同时性多原发性癌,207例(71.4%)为异时性多原发性癌。248例(85.5%)患者以其他恶性肿瘤为首发,甲状腺癌为后发现。本研究以女性256例(88.3%)、年龄≥45岁191例(65.9%)、甲状腺乳头状癌281例(96.9%)多见。甲状腺癌最常合并的原发癌是乳腺癌44.5%(129/290),其次是宫颈癌、肺癌、结直肠癌等。
      结论  年龄≥45岁女性恶性肿瘤患者,尤其是乳腺癌患者,在随访复查过程中建议进行甲状腺癌筛查。

     

    Abstract:
      Objective  To analyze the clinical and pathological features of multiple primary malignancies involving thyroid cancer.
      Methods  A retrospective study of 4, 861 thyroid cancer cases was performed. All patients were diagnosed at Yunnan Cancer Hospital between October 2007 and March 2017; among them, 290 patients harbored multiple primary malignancies involving thyroid cancer.Their clinical and pathological features were analyzed.
      Results  Among the 290 patients with multiple primary malignancies involving thyroid cancer, 7 (2.4%) had three malignancies and 283 (97.6%) had two malignancies. Eighty-three cases (28.6%) were synchronous multiple primary malignancies, and 207 cases (71.4%) were metachronous ones. Two hundred and forty-eight patients (85.5%) were primarily diagnosed with non-thyroid primary malignancies, and 42 patients (14.5%) had thyroid cancer as their primary diagnosis. Among 290 patients with multiple primary malignancies involving thyroid cancer, women (256, 88.3%), age ≥45 years (191, 65.9%), and presence of papillary thyroid carcinoma (281, 96.9%) were more common characteristics. Breast cancer was the most frequent accompanying disease (129, 44.5%), followed by cervical cancer (47, 16.2%), lung cancer (28, 9.7%), and colon cancer (17, 5.9%).
      Conclusions  Female cancer patients aged ≥45 years, especially those with breast cancer, should undergo thyroid disease screening during their follow-up period.

     

/

返回文章
返回